Panavance Therapeutics
Our Science
Pipeline
About Misetionamide
Mechanism of Action
About
About Persevere
Leadership
Advisors
Contact Persevere
Resources
Publications
Press Releases
Let’s engage
.
An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250 on Cutaneous Squamous Cell Carcinoma Cell Lines: Preliminary Results
December 10, 2023
/
0 Minute Read